OTCMKTS:DCTH - Delcath Systems Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Delcath Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.04 0.00 (0.00 %) (As of 12/6/2019 04:00 PM ET) Add Compare Today's Range$0.04Now: $0.04▼$0.0550-Day Range$0.04MA: $0.06▼$0.1052-Week Range$0.04Now: $0.04▼$39.99Volume142,854 shsAverage Volume52,191 shsMarket Capitalization$991,911.00P/E RatioN/ADividend YieldN/ABeta0.03 ProfileAdvanced ChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company is developing melphalan hydrochloride for Injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. It offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:DCTH Previous Symbol CUSIPN/A CIK872912 Webhttp://www.delcath.com/ Phone212-489-2100Debt Debt-to-Equity RatioN/A Current Ratio0.53 Quick Ratio0.50Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$3.41 million Price / Sales0.29 Cash FlowN/A Price / Cash FlowN/A Book Value($1.45) per share Price / Book-0.03Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-19,220,000.00 Net Margins-1,546.38% Return on EquityN/A Return on Assets-343.56%Miscellaneous Employees46 Outstanding Shares23,505,000Market Cap$991,911.00 Next Earnings Date6/12/2020 (Estimated) OptionableNot Optionable Receive DCTH News and Ratings via Email Sign-up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter. OTC:DCTH Rates by TradingView Delcath Systems (OTCMKTS:DCTH) Frequently Asked Questions What is Delcath Systems' stock symbol? Delcath Systems trades on the OTCMKTS under the ticker symbol "DCTH." When did Delcath Systems' stock split? How did Delcath Systems' stock split work? Delcath Systems shares reverse split on the morning of Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 21st 2019. An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 1 shares after the split. When is Delcath Systems' next earnings date? Delcath Systems is scheduled to release their next quarterly earnings announcement on Friday, June 12th 2020. View Earnings Estimates for Delcath Systems. Has Delcath Systems been receiving favorable news coverage? Media stories about DCTH stock have been trending very positive this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Delcath Systems earned a daily sentiment score of 4.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Delcath Systems. Who are some of Delcath Systems' key competitors? Some companies that are related to Delcath Systems include AdvanSource Biomaterials Corpration (ASNB), Sintx Technologies (SINT), Invivo Therapeutics (NVIV), Calmare Therapeutics (CTTC), Nuvectra (NVTR), United American Healthcare (UAHC), Regenicin (RGIN), Cytocore (MDIT), Hypertension Diagnostics (HDII), PlusTherapeuticsInc . (PSTV), TearLab (TEAR), Quantrx Biomedical (QTXB), Lombard Medical (EVARF), Oncologix Tech (OCLG) and Prourocare Medical (PUMD). What other stocks do shareholders of Delcath Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Delcath Systems investors own include General Electric (GE), Delcath Systems (DCTHD), Cronos Group (CRON), Achillion Pharmaceuticals (ACHN), AcelRx Pharmaceuticals (ACRX), Amarin (AMRN), Activision Blizzard (ATVI), AVEO Pharmaceuticals (AVEO), Broadcom (AVGO) and Anavex Life Sciences (AVXL). Who are Delcath Systems' key executives? Delcath Systems' management team includes the folowing people: Dr. Jennifer K. Simpson, Pres, CEO & Director (Age 51)Ms. Barbra C. Keck M.B.A., MBA, CFO & Sec. (Age 41)Mr. John Purpura, Exec. VP & Global Head of Operations (Age 58)Mr. Thomas Johnson, Sr. Director of Corp. CommunicationsMr. Robin Wagge, Sr. VP of Rubenstein Associates How do I buy shares of Delcath Systems? Shares of DCTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Delcath Systems' stock price today? One share of DCTH stock can currently be purchased for approximately $0.04. How big of a company is Delcath Systems? Delcath Systems has a market capitalization of $991,911.00 and generates $3.41 million in revenue each year. Delcath Systems employs 46 workers across the globe.View Additional Information About Delcath Systems. What is Delcath Systems' official website? The official website for Delcath Systems is http://www.delcath.com/. How can I contact Delcath Systems? Delcath Systems' mailing address is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. The company can be reached via phone at 212-489-2100 or via email at [email protected] MarketBeat Community Rating for Delcath Systems (OTCMKTS DCTH)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 19 (Vote Outperform)Underperform Votes: 18 (Vote Underperform)Total Votes: 37MarketBeat's community ratings are surveys of what our community members think about Delcath Systems and other stocks. Vote "Outperform" if you believe DCTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DCTH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/7/2019 by MarketBeat.com StaffFeatured Article: How do buyers and sellers choose a strike price?
